Cresemba and Ranitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cresemba (isavuconazonium sulfate) and Ranitidine (ranitidine). Common drug interactions include adenocarcinoma among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Cresemba and Ranitidine. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Cresemba?

Cresemba has active ingredients of isavuconazonium sulfate. eHealthMe is studying from 2,574 Cresemba users. Check the latest studies of Cresemba.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

On Jul, 11, 2026

12 people who take Cresemba and Ranitidine together, and have interactions are studied.

Cresemba and Ranitidine drug interactions.

What are the common drug interactions of Cresemba and Ranitidine, by gender? *:

female:

Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue)
Arthralgia (joint pain)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Nodule (a growth of abnormal tissue)
Death
Fall
Hospitalisation

male:

Confusional state
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Plasma cell myeloma (cancer that begins in plasma cells)
Platelet count decreased
Respiratory failure (inadequate gas exchange by the respiratory system)
Subdural haematoma (blood collects between the skull and the surface of the brain)
Thrombosis (formation of a blood clot inside a blood vessel)
Febrile neutropenia (fever with reduced white blood cells)
Lung transplant

What are the common drug interactions of Cresemba and Ranitidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Lung transplant

40-49:

n/a

50-59:

n/a

60+:

Confusional state
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Nodule (a growth of abnormal tissue)
Fall
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hospitalisation
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Plasma cell myeloma (cancer that begins in plasma cells)
Platelet count decreased
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 25.00%
Cystic Fibrosis (disease of the secretary glands): 3 people, 25.00%
Parkinson's Disease: 2 people, 16.67%
High Blood Pressure: 1 person, 8.33%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 8.33%
Bipolar Disorder (mood disorder): 1 person, 8.33%
Depression: 1 person, 8.33%
Diabetes: 1 person, 8.33%
Fungal Infection: 1 person, 8.33%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cresemba and Ranitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously